$22.21
3.79%
Nasdaq, Sep 02, 10:00 pm CET
ISIN
US35803L1089
Symbol
KRRO

Frequency Therapeutics Inc Target price 2025 - Analyst rating & recommendation

Frequency Therapeutics Inc Classifications & Recommendation:

Buy
94%
Hold
6%

Frequency Therapeutics Inc Price Target

Target Price $86.70
Price $22.21
Potential
Number of Estimates 11
11 Analysts have issued a price target Frequency Therapeutics Inc 2026 . The average Frequency Therapeutics Inc target price is $86.70. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 16 analysts: 15 Analysts recommend Frequency Therapeutics Inc to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Frequency Therapeutics Inc stock has an average upside potential 2026 of . Most analysts recommend the Frequency Therapeutics Inc stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 2.27 4.48
97.36%
Net Margin -3,681.94% -2,087.07%
43.32%

12 Analysts have issued a sales forecast Frequency Therapeutics Inc 2025 . The average Frequency Therapeutics Inc sales estimate is

$4.5m
Unlock
. This is
28.66% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$8.1m 29.22%
Unlock
, the lowest is
$2.5m 60.21%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $2.3m
2025
$4.5m 97.36%
Unlock
2026
$1.2m 74.20%
Unlock
2027
$437k 62.19%
Unlock
2028
$3.2m 629.58%
Unlock
2029
$127m 3,877.11%
Unlock
2030
$483m 280.79%
Unlock
2031
$811m 67.88%
Unlock
2032
$1.6b 95.24%
Unlock

12 Frequency Therapeutics Inc Analysts have issued a net profit forecast 2025. The average Frequency Therapeutics Inc net profit estimate is

$-93.5m
Unlock
. This is
2.34% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-85.4m 6.55%
Unlock
, the lowest is
$-103m 12.92%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-83.6m 2.97%
2025
$-93.5m 11.87%
Unlock
2026
$-91.9m 1.73%
Unlock
2027
$-95.9m 4.32%
Unlock
2028
$-126m 31.10%
Unlock
2029
$-79.5m 36.73%
Unlock
2030
$124m 256.55%
Unlock
2031
$25.5m 79.48%
Unlock
2032
$207m 710.02%
Unlock

Net Margin

2024 -3,681.94%
2025
-2,087.07% 43.32%
Unlock
2026
-7,948.36% 280.84%
Unlock
2027
-21,925.72% 175.85%
Unlock
2028
-3,940.44% 82.03%
Unlock
2029
-62.69% 98.41%
Unlock
2030
25.77% 141.11%
Unlock
2031
3.15% 87.78%
Unlock
2032
13.07% 314.92%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -9.37 -9.96
7.50% 6.30%
P/E negative
EV/Sales 25.04

12 Analysts have issued a Frequency Therapeutics Inc forecast for earnings per share. The average Frequency Therapeutics Inc EPS is

$-9.96
Unlock
. This is
2.47% lower
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$-9.09 6.48%
Unlock
, the lowest is
$-10.99 13.07%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-9.37 7.50%
2025
$-9.96 6.30%
Unlock
2026
$-9.79 1.71%
Unlock
2027
$-10.21 4.29%
Unlock
2028
$-13.38 31.05%
Unlock
2029
$-8.47 36.70%
Unlock
2030
$13.26 256.55%
Unlock
2031
$2.72 79.49%
Unlock
2032
$22.03 709.93%
Unlock

P/E ratio

Current -2.28 50.88%
2025
-2.23 2.39%
Unlock
2026
-2.27 1.79%
Unlock
2027
-2.18 3.96%
Unlock
2028
-1.66 23.85%
Unlock
2029
-2.62 57.83%
Unlock
2030
1.68 164.12%
Unlock
2031
8.16 385.71%
Unlock
2032
1.01 87.62%
Unlock

Based on analysts' sales estimates for 2025, the Frequency Therapeutics Inc stock is valued at an EV/Sales of

25.04
Unlock
and an P/S ratio of
46.55
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 17.86
2025
25.04 40.19%
Unlock
2026
97.03 287.54%
Unlock
2027
256.60 164.45%
Unlock
2028
35.17 86.29%
Unlock
2029
0.88 97.49%
Unlock
2030
0.23 73.73%
Unlock
2031
0.14 40.46%
Unlock
2032
0.07 48.73%
Unlock

P/S ratio

Current
2025
46.55 40.18%
Unlock
2026
180.39 287.54%
Unlock
2027
477.03 164.45%
Unlock
2028
65.39 86.29%
Unlock
2029
1.64 97.49%
Unlock
2030
0.43 73.74%
Unlock
2031
0.26 40.44%
Unlock
2032
0.13 48.79%
Unlock

Current Frequency Therapeutics Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Chardan Capital
Locked
Locked
Locked Aug 13 2025
HC Wainwright & Co.
Locked
Locked
Locked Aug 13 2025
Raymond James
Locked
Locked
Locked Aug 13 2025
HC Wainwright & Co.
Locked
Locked
Locked Jul 24 2025
Oppenheimer
Locked
Locked
Locked May 13 2025
Chardan Capital
Locked
Locked
Locked May 13 2025
HC Wainwright & Co.
Locked
Locked
Locked May 08 2025
Analyst Rating Date
Locked
Chardan Capital:
Locked
Locked
Aug 13 2025
Locked
HC Wainwright & Co.:
Locked
Locked
Aug 13 2025
Locked
Raymond James:
Locked
Locked
Aug 13 2025
Locked
HC Wainwright & Co.:
Locked
Locked
Jul 24 2025
Locked
Oppenheimer:
Locked
Locked
May 13 2025
Locked
Chardan Capital:
Locked
Locked
May 13 2025
Locked
HC Wainwright & Co.:
Locked
Locked
May 08 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today